TY - JOUR
T1 - Recessive MYH7-related myopathy in two families
AU - Beecroft, Sarah J.
AU - van de Locht, Martijn
AU - de Winter, Josine M.
AU - Ottenheijm, Coen A.
AU - Sewry, Caroline A.
AU - Mohammed, Shehla
AU - Ryan, Monique M.
AU - Woodcock, Ian R.
AU - Sanders, Lauren
AU - Gooding, Rebecca
AU - Davis, Mark R.
AU - Oates, Emily C.
AU - Laing, Nigel G.
AU - Ravenscroft, Gianina
AU - McLean, Catriona A.
AU - Jungbluth, Heinz
N1 - Funding Information:
We would like to thank the families for their kind participation. We thank Homa Tajsharghi for insightful comments about myosin disease mechanisms. The authors would like to thank the Genome Aggregation Database (gnomAD) and the groups that provided exome and genome variant data to this resource. A full list of contributing groups can be found at https://gnomad.broadinstitute.org/about. This study was supported by Australian National Health and Medical Research Council (NHMRC) Fellowships APP1117510 (NGL) and APP1122952 (GR), GNTAPP1090428 (EO), NHMRC Project grant APP1080587. SB was supported by The Fred Liuzzi Foundation Neuromuscular PhD Scholarship. Funding for consumables came from the Fred Liuzzi Foundation, and NHMRC.
Funding Information:
We would like to thank the families for their kind participation. We thank Homa Tajsharghi for insightful comments about myosin disease mechanisms. The authors would like to thank the Genome Aggregation Database (gnomAD) and the groups that provided exome and genome variant data to this resource. A full list of contributing groups can be found at https://gnomad.broadinstitute.org/about . This study was supported by Australian National Health and Medical Research Council (NHMRC) Fellowships APP1117510 ( NGL ) and APP1122952 ( GR ), GNTAPP1090428 (EO), NHMRC Project grant APP1080587 . SB was supported by The Fred Liuzzi Foundation Neuromuscular PhD Scholarship. Funding for consumables came from the Fred Liuzzi Foundation, and NHMRC.
Publisher Copyright:
© 2019 Elsevier B.V.
PY - 2019/6
Y1 - 2019/6
N2 - Myopathies due to recessive MYH7 mutations are exceedingly rare, reported in only two families to date. We describe three patients from two families (from Australia and the UK) with a myopathy caused by recessive mutations in MYH7. The Australian family was homozygous for a c.5134C > T, p.Arg1712Trp mutation, whilst the UK patient was compound heterozygous for a truncating (c.4699C > T; p.Gln1567*) and a missense variant (c.4664A > G; p.Glu1555Gly). All three patients shared key clinical features, including infancy/childhood onset, pronounced axial/proximal weakness, spinal rigidity, severe scoliosis, and normal cardiac function. There was progressive respiratory impairment necessitating non-invasive ventilation despite preserved ambulation, a combination of features often seen in SEPN1- or NEB-related myopathies. On biopsy, the Australian proband showed classical myosin storage myopathy features, while the UK patient showed multi-minicore like areas. To establish pathogenicity of the Arg1712Trp mutation, we expressed mutant MYH7 protein in COS-7 cells, observing abnormal mutant myosin aggregation compared to wild-type. We describe skinned myofiber studies of patient muscle and hypertrophy of type II myofibers, which may be a compensatory mechanism. In summary, we have expanded the phenotype of ultra-rare recessive MYH7 disease, and provide novel insights into associated changes in muscle physiology.
AB - Myopathies due to recessive MYH7 mutations are exceedingly rare, reported in only two families to date. We describe three patients from two families (from Australia and the UK) with a myopathy caused by recessive mutations in MYH7. The Australian family was homozygous for a c.5134C > T, p.Arg1712Trp mutation, whilst the UK patient was compound heterozygous for a truncating (c.4699C > T; p.Gln1567*) and a missense variant (c.4664A > G; p.Glu1555Gly). All three patients shared key clinical features, including infancy/childhood onset, pronounced axial/proximal weakness, spinal rigidity, severe scoliosis, and normal cardiac function. There was progressive respiratory impairment necessitating non-invasive ventilation despite preserved ambulation, a combination of features often seen in SEPN1- or NEB-related myopathies. On biopsy, the Australian proband showed classical myosin storage myopathy features, while the UK patient showed multi-minicore like areas. To establish pathogenicity of the Arg1712Trp mutation, we expressed mutant MYH7 protein in COS-7 cells, observing abnormal mutant myosin aggregation compared to wild-type. We describe skinned myofiber studies of patient muscle and hypertrophy of type II myofibers, which may be a compensatory mechanism. In summary, we have expanded the phenotype of ultra-rare recessive MYH7 disease, and provide novel insights into associated changes in muscle physiology.
KW - Muscle physiology
KW - MYH7
KW - Myosin storage myopathy
KW - Myosinopathy
KW - Next generation sequencing
UR - http://www.scopus.com/inward/record.url?scp=85065909510&partnerID=8YFLogxK
U2 - 10.1016/j.nmd.2019.04.002
DO - 10.1016/j.nmd.2019.04.002
M3 - Article
C2 - 31130376
AN - SCOPUS:85065909510
SN - 0960-8966
VL - 29
SP - 456
EP - 467
JO - Neuromuscular Disorders
JF - Neuromuscular Disorders
IS - 6
ER -